Glaukos Corp Stock Market Value
| GKOS Stock | USD 120.27 3.17 2.71% |
| Symbol | Glaukos |
Is there potential for Health Care Equipment & Supplies market expansion? Will Glaukos introduce new products? Factors like these will boost the valuation of Glaukos Corp. Market participants price Glaukos higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Glaukos Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 18.963 | Earnings Share (1.54) | Revenue Per Share | Quarterly Revenue Growth 0.357 | Return On Assets |
Investors evaluate Glaukos Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Glaukos Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Glaukos Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Glaukos Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Glaukos Corp's market price signifies the transaction level at which participants voluntarily complete trades.
Glaukos Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Glaukos Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Glaukos Corp.
| 11/22/2025 |
| 02/20/2026 |
If you would invest 0.00 in Glaukos Corp on November 22, 2025 and sell it all today you would earn a total of 0.00 from holding Glaukos Corp or generate 0.0% return on investment in Glaukos Corp over 90 days. Glaukos Corp is related to or competes with TransMedics, IRhythm Technologies, Bausch Lomb, Merit Medical, Bruker, Alkermes Plc, and Arcellx. Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel th... More
Glaukos Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Glaukos Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Glaukos Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.2 | |||
| Information Ratio | 0.1129 | |||
| Maximum Drawdown | 14.33 | |||
| Value At Risk | (3.93) | |||
| Potential Upside | 5.29 |
Glaukos Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Glaukos Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Glaukos Corp's standard deviation. In reality, there are many statistical measures that can use Glaukos Corp historical prices to predict the future Glaukos Corp's volatility.| Risk Adjusted Performance | 0.1097 | |||
| Jensen Alpha | 0.3576 | |||
| Total Risk Alpha | 0.1878 | |||
| Sortino Ratio | 0.1601 | |||
| Treynor Ratio | 0.4521 |
Glaukos Corp February 20, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1097 | |||
| Market Risk Adjusted Performance | 0.4621 | |||
| Mean Deviation | 2.15 | |||
| Semi Deviation | 1.97 | |||
| Downside Deviation | 2.2 | |||
| Coefficient Of Variation | 750.04 | |||
| Standard Deviation | 3.12 | |||
| Variance | 9.72 | |||
| Information Ratio | 0.1129 | |||
| Jensen Alpha | 0.3576 | |||
| Total Risk Alpha | 0.1878 | |||
| Sortino Ratio | 0.1601 | |||
| Treynor Ratio | 0.4521 | |||
| Maximum Drawdown | 14.33 | |||
| Value At Risk | (3.93) | |||
| Potential Upside | 5.29 | |||
| Downside Variance | 4.84 | |||
| Semi Variance | 3.9 | |||
| Expected Short fall | (2.70) | |||
| Skewness | 1.51 | |||
| Kurtosis | 4.52 |
Glaukos Corp Backtested Returns
Glaukos Corp appears to be very steady, given 3 months investment horizon. Glaukos Corp holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Glaukos Corp, which you can use to evaluate the volatility of the firm. Please utilize Glaukos Corp's market risk adjusted performance of 0.4621, and Risk Adjusted Performance of 0.1097 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Glaukos Corp holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 0.9, which attests to possible diversification benefits within a given portfolio. Glaukos Corp returns are very sensitive to returns on the market. As the market goes up or down, Glaukos Corp is expected to follow. Please check Glaukos Corp's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Glaukos Corp's current trending patterns will revert.
Auto-correlation | 0.04 |
Virtually no predictability
Glaukos Corp has virtually no predictability. Overlapping area represents the amount of predictability between Glaukos Corp time series from 22nd of November 2025 to 6th of January 2026 and 6th of January 2026 to 20th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Glaukos Corp price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Glaukos Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 32.35 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.